Define product scope
Confirm oncology product types, volumes, handling requirements, and destination market documentation needs.
Therapeutic Areas
Source high-value cancer therapeutics — immunotherapy, chemotherapy, and targeted treatments — through licensed US wholesaler channels with export-ready documentation.
Oncology portfolios combine high-value products, strict handling requirements, and complex cross-border documentation. McHade sources immunotherapy, chemotherapy, and targeted treatments through a registered US pharmaceutical wholesaler — with batch records and export paperwork aligned to your destination market.
Many oncology programs span commercial supply, institutional tenders, and clinical study support. McHade coordinates sourcing with the handling controls and documentation your QA and regulatory teams expect — whether product moves at ambient conditions or requires 2–8°C cold-chain aware handling for biologic oncology therapies.
Oncology sourcing integrates with McHade clinical trial, global procurement, and logistics services as your program requires — each capability can be scoped and engaged independently.
Who it's for
What's covered
How it works
A clear operating path from product scoping through documented cross-border delivery.
Confirm oncology product types, volumes, handling requirements, and destination market documentation needs.
Identify licensed wholesaler channels and verify product availability against your program timeline.
Procure with batch records, controlled handling protocols, and chain-of-custody documentation for QA review.
Prepare export documentation and coordinate cross-border delivery with your clearing agent and local partners.
Share your oncology product categories, handling needs, destination markets, and program scope. Our team will review the requirements and respond with a compliant sourcing approach — turnaround depends on product complexity and market requirements.